Home › Follicular Lymphoma › Connecticut › Bridgeport
Follicular Lymphoma clinical trials in Bridgeport, CT
4 studies for Follicular Lymphoma are looking for participants at sites in and around Bridgeport (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi away
- Stony Brook University Medical Center, Stony Brook · 18 mi away
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
RecruitingPhase 3
- Stony Brook University Hospital, Stony Brook · 18 mi away
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi away
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
RecruitingPhase 3
- Stony Brook University Hospital, Stony Brook · 18 mi away
Follicular Lymphoma trials in other cities
- New York City, NY24 studies
- Milwaukee, WI19 studies
- Nashville, TN18 studies
- Houston, TX18 studies
- Boston, MA17 studies
- Baldwin Park, CA16 studies
- Seattle, WA15 studies
- Durham, NC15 studies
- Columbus, OH13 studies
- Salt Lake City, UT13 studies
- Philadelphia, PA12 studies
- Chicago, IL12 studies
Other studies in Bridgeport
- Breast Cancer21 studies
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Acute Myeloid Leukemia12 studies
- Cardiovascular Disease9 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Cancer (all types)8 studies
- Metastatic Cancer7 studies
- Heart Failure7 studies
- Brain Aneurysm6 studies
- Prostate Cancer6 studies
- Multiple Myeloma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.